CLDN18.2

Close
Menu
Close up of microscope in laboratory setting with overlaid green abstract pattern on dark background

CLDN18.2:
test and interpret with confidence

Help identify a specific subpopulation of patients with gastric / gastroesophageal junction (G/GEJ) adenocarcinoma to help guide treatment approaches.

Peer perspectives

Hear from some of the world’s leading pathologists discussing how they test, interpret, and report CLDN18.2 expression.

CLDN18.2 expert committee

Dr. Matteo Fassan profile picture

Matteo Fassan, MD, PhD

Padua, Italy

See Profile
Dr. Takeshi Kuwata profile picture

Takeshi Kuwata, MD, PhD

Tokyo, Japan

See Profile
Dr. Kristina Matkowskyj profile picture

Kristina A. Matkowskyj, MD, PhD

Rochester, MN, USA

See Profile
Dr. Cristoph Rocken profile picture

Christoph Röcken, MD

Kiel, Germany

See Profile
Dr. Josef H. Ruschoff profile picture

Josef H. Rüschoff,  MD

Kassel, Germany

See Profile

The experts above have been contracted as paid advisors through Astellas Pharma Inc. and have received compensation for their time.

The content on this website has been created by Astellas Pharma Inc. and may or may not reflect the views of the experts shown above unless explicitly specified.

CLDN18.2=claudin 18 isoform 2. G/GEJ=gastric/gastroesophageal junction.

stain-interpretation-home-mobile

Review whole slide images and test your interpretation skills

Abstract pattern of aqua green circles
IMAGE